Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2010-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pbb.2010.07.010PMID 20643159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erratum to: Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat

  2011cited by this paper
• FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.

  2009influential reference
• Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration—comparison with CB1 receptor blockade

  2009influential reference
• Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat

  2008cited by this paper
• The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat

  2008influential reference
• The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.

  2008influential reference
• Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks.

  2008cited by this paper
• Inhibition of Anandamide Hydrolysis by Cyclohexyl Carbamic Acid 3′-Carbamoyl-3-yl Ester (URB597) Reverses Abuse-Related Behavioral and Neurochemical Effects of Nicotine in Rats

  2008influential reference
• An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

  2007cited by this paper
• The anandamide transport inhibitor AM404 reduces ethanol self‐administration

  2007cited by this paper
• The Endocannabinoid System and Extinction Learning

  2007cited by this paper
• The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats

  2006cited by this paper
• Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat

  2006influential reference
• Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling

  2006influential reference
• Erratum: Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis (Proceedings of the National Academy of Sciences of the United States of America (December 20, 2005) 102, 51 (18620-18625) DOI: 10.1073/pnas.0509591102)

  2006influential reference
• Correction for Gobbi et al., Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

  2005influential reference
• Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear

  2005cited by this paper
• Cannabinoid CB1 receptor is dispensable for memory extinction in an appetitively-motivated learning task.

  2005cited by this paper
• Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation

  2005cited by this paper
• Characterization of the fatty-acid amide hydrolase inhibitor URB 597 : Effects on anandamide and oleoylethanolamide deactivation

  2004influential reference
• Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal

  2003cited by this paper
• Modulation of anxiety through blockade of anandamide hydrolysis

  2003influential reference
• Context, ambiguity, and unlearning: sources of relapse after behavioral extinction.

  2002cited by this paper
• The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning.

  2002cited by this paper
• The endogenous cannabinoid system controls extinction of aversive memories

  2002cited by this paper
• Evaluation of CB1 receptor knockout mice in the Morris water maze.

  2002cited by this paper
• Reinstatement of both a conditioned place preference and a conditioned place aversion with drug primes.

  2000cited by this paper
• Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine.

  1998cited by this paper

• FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders.

  2025cites this paper
• A Translational Approach to Using Endocannabinoid Modulators for Targeting Opioid-Associated Memory

  2024cites this paper
• Cannabinoid treatment of opiate addiction

  2021cites this paper
• Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague–Dawley rats

  2019cites this paper
• Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders

  2019cites this paper
• Brain activity of anandamide: a rewarding bliss?

  2018cites this paper
• Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation.

  2017cites this paper
• CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats

  2014cites this paper
• Role of the Endocannabinoid System in Extinction of Learned Behaviours Motivated by Opioid-Induced Reward and Aversion in Rats

  2013cites this paper
• Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

  2013cites this paper
• A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’

  2011cites this paper
• Endogenous opiates and behavior: 2010.

  2011cites this paper